We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+14.59%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$416M
AUM Growth
+$5.73M
Cap. Flow
-$28.5M
Cap. Flow %
-6.86%
Top 10 Hldgs %
18.98%
Holding
147
New
30
Increased
29
Reduced
49
Closed
32

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$5.71M
2
AVAV icon
AeroVironment
AVAV
+$4.55M
3
ULS icon
UL Solutions
ULS
+$4.3M
4
PCRX icon
Pacira BioSciences
PCRX
+$3.95M
5
FN icon
Fabrinet
FN
+$3.91M

Top Sells

Rank Stock Value
1
CNM icon
Core & Main
CNM
+$9.04M
2
MOD icon
Modine Manufacturing
MOD
+$8.11M
3
NTNX icon
Nutanix
NTNX
+$6.08M
4
FROG icon
JFrog
FROG
+$5.32M
5
KNSL icon
Kinsale Capital Group
KNSL
+$4.96M

Sector Composition

Rank Sector Weight
1 Technology 26.49%
2 Industrials 26.26%
3 Healthcare 20.82%
4 Consumer Discretionary 13.64%
5 Consumer Staples 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMED icon
101
Globus Medical
GMED
$10.9B
$1.01M 0.24%
+14,795
New +$884K
BURL icon
102
Burlington
BURL
$23.2B
$958K 0.23%
+3,990
New +$821K
APLS
103
DELISTED
Apellis Pharmaceuticals
APLS
$955K 0.23%
24,885
-64,325
-72% -$2.91M
NBIX icon
104
Neurocrine Biosciences
NBIX
$16.4B
$916K 0.22%
6,650
VRT icon
105
Vertiv
VRT
$107B
$825K 0.2%
9,525
-2,920
-23% -$266K
WSM icon
106
Williams-Sonoma
WSM
$29.2B
$805K 0.19%
5,700
+2,440
+75% +$364K
HAS icon
107
Hasbro
HAS
$12.9B
$771K 0.19%
+13,180
New +$782K
WSC icon
108
WillScot Mobile Mini Holdings
WSC
$4.81B
$717K 0.17%
19,040
-8,225
-30% -$325K
MEDP icon
109
Medpace
MEDP
$16.4B
$708K 0.17%
1,720
-1,870
-52% -$741K
BLD
110
DELISTED
TopBuild
BLD
$668K 0.16%
1,735
-1,620
-48% -$660K
MANH icon
111
Manhattan Associates
MANH
$11.2B
$662K 0.16%
2,685
-3,030
-53% -$687K
DECK icon
112
Deckers Outdoor
DECK
$13.5B
$658K 0.16%
4,080
-3,660
-47% -$563K
SGI
113
Somnigroup International
SGI
$14.6B
$601K 0.14%
+12,685
New +$642K
IONS icon
114
Ionis Pharmaceuticals
IONS
$9.01B
$517K 0.12%
10,845
-16,990
-61% -$697K
GAP
115
The Gap Inc
GAP
$7.4B
$388K 0.09%
+16,230
New +$377K
ARCB icon
116
ArcBest
ARCB
$3.17B
-24,730
Closed -$3.52M
AVDX
117
DELISTED
AvidXchange
AVDX
-167,715
Closed -$2.21M
BRZE icon
118
Braze
BRZE
$2.95B
-54,060
Closed -$2.39M
CAVA icon
119
CAVA Group
CAVA
$7.71B
-31,455
Closed -$2.2M
CNM icon
120
Core & Main
CNM
$8.71B
-157,865
Closed -$9.04M
EVH icon
121
Evolent Health
EVH
$346M
-52,060
Closed -$1.71M
EXAS
122
DELISTED
Exact Sciences
EXAS
-11,110
Closed -$767K
FCFS icon
123
FirstCash
FCFS
$9.02B
-22,485
Closed -$2.87M
FLYW icon
124
Flywire
FLYW
$2.3B
-172,280
Closed -$4.27M
FROG icon
125
JFrog
FROG
$10.2B
-120,285
Closed -$5.32M

Similar funds

Lisanti Capital Growth's Q2 2024 Portfolio in Review

As of Q2 2024, Lisanti Capital Growth held 147 positions worth $416M, up 1.4% from $410M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $28.5M in Q2 2024, closing 32 positions and reducing 49 holdings. Its most notable exit was Core & Main, an estimated $9.04M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Lantheus worth $6.25M.

  • Lisanti Capital Growth's largest Q2 2024 buy was Lantheus: 77,875 shares worth $6.25M.
  • Lisanti Capital Growth added most to Commault Systems in Q2 2024, an estimated $3.17M increase.
  • Lisanti Capital Growth's biggest Q2 2024 reduction was Modine Manufacturing, cutting an estimated $8.11M.
  • Lisanti Capital Growth fully exited Core & Main in Q2 2024, selling an estimated $9.04M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $416M portfolio in Q2 2024.
  • Lisanti Capital Growth opened 30 new positions and closed 32 in Q2 2024.
  • Lisanti Capital Growth's portfolio value rose 1.4% quarter-over-quarter to $416M.

Based on Lisanti Capital Growth's 13F filing for Q2 2024, filed 1 Aug 2024.